GSK GlaxoSmithKline Plc

44.26-0.16 (-0.36%)
Close: November 11, 2019

Quote

Previous Close
$44.26
Day Range
$43.99-$44.28
52 Week Range
$36.41-$46.01
Volume
1,974,151
Avg Volume
2,659,111
Dividend TTM
$2.51 (5.66%)
Ex-Dividend Date
2019-11-14

Valuation

Market Cap
$109.59B
Enterprise Value (EV)
$138.14B
PE Ratio
18.86
EV/EBITDA
10.51
Price/Sales
2.68
Price/Book
19.74
PEG Ratio
1.98

Financials

Revenue
$41.10B
Gross Profit
$27.90B
EBITDA
$13.14B
EPS, ttm
$2.35
Profit Margin
11.75%
Revenue/Employee
$430.38K
Next Earnings Date
2/5/2020 (86 days)
Debt to Equity
598%
Debt
$33.59B
Cash
$5.04B
Net Debt
$28.55B

Performance

Beta
0.30
200 Day Moving Avg
$40.98
50 Day Moving Avg
$42.55
52 Week Change
7.55%
YTD Change
16.91%
1 Month Change
6.06%
3 Month Change
9.68%
6 Month Change
11.78%
1 Year Change
7.71%
2 Year Change
21.77%
5 Year Change
-1.64%

Share Count

Shares Outstanding
2.5B
Float
2.5B
Restricted Shares
24.8K
Restricted Shares, %
0.00%

GlaxoSmithKline Plc Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Emma Walmsley

Website: http://gsk.com

Description: GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees: 95,490